Harvard Apparatus Regenerative Technology Inc.
HRGN
$1.87
$0.01991.08%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 258.00K | 59.00K | 56.00K | 57.00K | 63.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 258.00K | 59.00K | 56.00K | 57.00K | 63.00K |
| Cost of Revenue | 175.00K | 70.00K | 13.00K | 12.00K | 11.00K |
| Gross Profit | 83.00K | -11.00K | 43.00K | 45.00K | 52.00K |
| SG&A Expenses | 1.20M | 1.31M | 1.39M | 1.24M | 1.25M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.62M | 1.92M | 2.04M | 2.08M | 1.89M |
| Operating Income | -1.37M | -1.86M | -1.98M | -2.02M | -1.83M |
| Income Before Tax | -1.34M | -1.86M | -2.50M | -2.03M | -1.83M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.34M | -1.86M | -2.50M | -2.03M | -1.83M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.34M | -1.86M | -2.50M | -2.03M | -1.83M |
| EBIT | -1.37M | -1.86M | -1.98M | -2.02M | -1.83M |
| EBITDA | -1.36M | -1.86M | -1.98M | -2.02M | -1.82M |
| EPS Basic | -0.08 | -0.12 | -0.18 | -0.15 | -0.13 |
| Normalized Basic EPS | -0.05 | -0.08 | -0.09 | -0.09 | -0.08 |
| EPS Diluted | -0.08 | -0.12 | -0.18 | -0.15 | -0.13 |
| Normalized Diluted EPS | -0.05 | -0.08 | -0.09 | -0.09 | -0.08 |
| Average Basic Shares Outstanding | 15.93M | 15.02M | 14.26M | 13.95M | 13.93M |
| Average Diluted Shares Outstanding | 15.93M | 15.02M | 14.26M | 13.95M | 13.93M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |